Oktober 31, 2006 | Foundation of Vela Laboratories, Appointment of Dr. Markus Fido as Managing Director |
November 2006 | Approval of AWS Seed Financing loan Approval of ZIT / LISA grants for R&D projects |
December 2006 | Bid for Igeneon infrastructure and lab equipment (together with Greenovation Biopharma) for selected Igeneon projects |
January 2007 | Confirmation of the asset deals (infrastructure and projects) by court of law (start of the business) |
February 2007 | Approval of ZIT / LISA project grant `Innovations - Support´ |
April 2007 | Signing of a lease contract for analytical laboratories with ImmoRent / Arealis |
June 2007 | Closing 1st round atypical investors |
September 2007 | Expansion of office space Signing of Co-Development contract with Greenovation |
October 2007 | Appointment of Dr. Andreas Nechansky as 'Authorized Representatives' of Vela Labs |
November 2007 | GMP certification of Vela Laboratories by AGES Austria |
December 2007 | Closing 3rd round atypical investors |
January 2007 | Foundation of Meridian Biopharmaceuticals GmbH |
April 2008 | Start of the operative separation Vela (Analytical Service Provider) - Meridian (Project Development) |
July 2008 | Canadian customer acquired for analytical service business |
November 2008 | First Prize ZIT call "CoOperate Enlarged" |
December 2008 | Vela sales reach 500T€ (export quote: 55%) |
March 2009 | Indian customer acquired for analytical service business |
June 2009 | Dr. Kricek joins Vela Scientific Advisory Board |
September 2009 | Launch of marketing initiative focusing on cellular Bioassays |
December 2009 | Vela sales reach 1,0 mio € (export quote: 65%) |
February 2010 | Vela and Meridian are two legally separated companies |
April 2010 | Signing of cooperation contract with NBS-C BioScience |
September 2010 | Renewal of GMP certification by AGES Austria (until June 2013) |
Dezember 2010 | Vela sales reach € 1,9 mio. (export quota: 79%) |
